Literature DB >> 22730134

Motion of transfer RNA from the A/T state into the A-site using docking and simulations.

Thomas Caulfield1, Batsal Devkota.   

Abstract

The ribosome catalyzes peptidyl transfer reactions at the growing nascent polypeptide chain. Here, we present a structural mechanism for selecting cognate over near-cognate A/T transfer RNA (tRNA). In part, the structural basis for the fidelity of translation relies on accommodation to filter cognate from near-cognate tRNAs. To examine the assembly of tRNAs within the ribonucleic-riboprotein complex, we conducted a series of all-atom molecular dynamics (MD) simulations of the entire solvated 70S Escherichia coli ribosome, along with its associated cofactors, proteins, and messenger RNA (mRNA). We measured the motion of the A/T state of tRNA between initial binding and full accommodation. The mechanism of rejection was investigated. Using novel in-house algorithms, we determined trajectory pathways. Despite the large intersubunit cavity, the available space is limited by the presence of the tRNA, which is equally large. This article describes a "structural gate," formed between helices 71 and 92 on the ribosomal large subunit, which restricts tRNA motion. The gate and the interacting protein, L14, of the 50S ribosome act as steric filters in two consecutive substeps during accommodation, each requiring: (1) sufficient energy contained in the hybrid tRNA kink and (2) sufficient energy in the Watson-Crick base pairing of the codon-anticodon. We show that these barriers act to filter out near-cognate tRNA and promote proofreading of the codon-anticodon. Since proofreading is essential for understanding the fidelity of translation, our model for the dynamics of this process has substantial biomedical implications.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22730134     DOI: 10.1002/prot.24131

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  33 in total

1.  Computational docking simulations of a DNA-aptamer for argininamide and related ligands.

Authors:  H Bauke Albada; Eyal Golub; Itamar Willner
Journal:  J Comput Aided Mol Des       Date:  2015-04-16       Impact factor: 3.686

2.  Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.

Authors:  Fabienne C Fiesel; Thomas R Caulfield; Elisabeth L Moussaud-Lamodière; Kotaro Ogaki; Daniel F A R Dourado; Samuel C Flores; Owen A Ross; Wolfdieter Springer
Journal:  Hum Mutat       Date:  2015-06-03       Impact factor: 4.878

3.  Long-range electrostatic complementarity governs substrate recognition by human chymotrypsin C, a key regulator of digestive enzyme activation.

Authors:  Jyotica Batra; András Szabó; Thomas R Caulfield; Alexei S Soares; Miklós Sahin-Tóth; Evette S Radisky
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

Review 4.  Activation of the E3 ubiquitin ligase Parkin.

Authors:  Thomas R Caulfield; Fabienne C Fiesel; Wolfdieter Springer
Journal:  Biochem Soc Trans       Date:  2015-04       Impact factor: 5.407

5.  An Acrobatic Substrate Metamorphosis Reveals a Requirement for Substrate Conformational Dynamics in Trypsin Proteolysis.

Authors:  Olumide Kayode; Ruiying Wang; Devon F Pendlebury; Itay Cohen; Rachel D Henin; Alexandra Hockla; Alexei S Soares; Niv Papo; Thomas R Caulfield; Evette S Radisky
Journal:  J Biol Chem       Date:  2016-11-03       Impact factor: 5.157

6.  Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15.

Authors:  Xin Wang; Pádraig D'Arcy; Thomas R Caulfield; Aneel Paulus; Kasyapa Chitta; Chitralekha Mohanty; Joachim Gullbo; Asher Chanan-Khan; Stig Linder
Journal:  Chem Biol Drug Des       Date:  2015-05-27       Impact factor: 2.817

Review 7.  RNA Structural Dynamics As Captured by Molecular Simulations: A Comprehensive Overview.

Authors:  Jiří Šponer; Giovanni Bussi; Miroslav Krepl; Pavel Banáš; Sandro Bottaro; Richard A Cunha; Alejandro Gil-Ley; Giovanni Pinamonti; Simón Poblete; Petr Jurečka; Nils G Walter; Michal Otyepka
Journal:  Chem Rev       Date:  2018-01-03       Impact factor: 60.622

8.  Molecular Inhibitor of QSOX1 Suppresses Tumor Growth In Vivo.

Authors:  Amber L Fifield; Paul D Hanavan; Douglas O Faigel; Eduard Sergienko; Andrey Bobkov; Nathalie Meurice; Joachim L Petit; Alysia Polito; Thomas R Caulfield; Erik P Castle; John A Copland; Debabrata Mukhopadhyay; Krishnendu Pal; Shamit K Dutta; Huijun Luo; Thai H Ho; Douglas F Lake
Journal:  Mol Cancer Ther       Date:  2019-10-01       Impact factor: 6.261

9.  Disulfide engineering of human Kunitz-type serine protease inhibitors enhances proteolytic stability and target affinity toward mesotrypsin.

Authors:  Itay Cohen; Matt Coban; Anat Shahar; Banumathi Sankaran; Alexandra Hockla; Shiran Lacham; Thomas R Caulfield; Evette S Radisky; Niv Papo
Journal:  J Biol Chem       Date:  2019-01-30       Impact factor: 5.157

10.  Multifaceted peptide assisted one-pot synthesis of gold nanoparticles for plectin-1 targeted gemcitabine delivery in pancreatic cancer.

Authors:  Krishnendu Pal; Farah Al-Suraih; Roberto Gonzalez-Rodriguez; Shamit Kumar Dutta; Enfeng Wang; H Shaun Kwak; Thomas R Caulfield; Jeffery L Coffer; Santanu Bhattacharya
Journal:  Nanoscale       Date:  2017-10-19       Impact factor: 7.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.